BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38342076)

  • 1. The adenomyosis/endometriosis IVF patient - call for clinical focus.
    Cozzolino M; Alsbjerg B; Pellicer A; Garcia-Velasco JA; Humaidan P
    Reprod Biomed Online; 2024 Apr; 48(4):103737. PubMed ID: 38342076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of the endometrial preparation protocols for frozen-thawed embryo transfer cycles in women with endometriosis.
    Yang J; Wen Y; Li D; Hou X; Peng B; Wang Z
    Reprod Biol Endocrinol; 2023 Sep; 21(1):83. PubMed ID: 37670354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualised luteal phase support in artificially prepared frozen embryo transfer cycles based on serum progesterone levels: a prospective cohort study.
    Álvarez M; Gaggiotti-Marre S; Martínez F; Coll L; García S; González-Foruria I; Rodríguez I; Parriego M; Polyzos NP; Coroleu B
    Hum Reprod; 2021 May; 36(6):1552-1560. PubMed ID: 33686413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial receptivity in adenomyosis and/or endometriosis.
    Pirtea P; de Ziegler D; Ayoubi JM
    Fertil Steril; 2023 May; 119(5):741-745. PubMed ID: 36914148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-individual variability of serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cycles.
    Bourdon M; Guihard C; Maignien C; Patrat C; Guibourdenche J; Chapron C; Santulli P
    Hum Reprod; 2024 Apr; 39(4):742-748. PubMed ID: 38332539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal progesterone administration secures a high ongoing pregnancy rate in a personalized Hormone Replacement Therapy Frozen Embryo Transfer (HRT-FET) protocol: a prospective interventional study.
    Alsbjerg B; Jensen MB; Povlsen BB; Elbaek HO; Laursen RJ; Kesmodel US; Humaidan P
    Hum Reprod; 2023 Nov; 38(11):2221-2229. PubMed ID: 37759346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer.
    Wang Y; Yi YC; Guu HF; Chen YF; Kung HF; Chang JC; Chen LY; Chuan ST; Chen MJ
    Sci Rep; 2023 Apr; 13(1):6741. PubMed ID: 37185812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis.
    Niu Z; Chen Q; Sun Y; Feng Y
    Gynecol Endocrinol; 2013 Dec; 29(12):1026-30. PubMed ID: 24006906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen dose tapering during luteal phase does not affect clinical outcomes after hormone replacement treatment-frozen-thawed embryo transfer cycles: a retrospective analysis.
    Jing Z; Xi H; Qianling Z; Lunquan S; Nenghui L; Yanping L
    Hum Reprod; 2019 Aug; 34(8):1479-1484. PubMed ID: 31310320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes in women with adenomyosis, undergoing artificial endometrial preparation with and without gonadotropin-releasing hormone agonist pretreatment in frozen embryo transfer cycles: An RCT.
    Eslami Moayed M; Moini A; Kashani L; Farid Mojtahedi M; Rezaee T; Tabasizadeh H; Maajani K; Yamini N
    Int J Reprod Biomed; 2023 Jun; 21(6):481-490. PubMed ID: 37560066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GnRH agonist supplementation in hormone replacement therapy-frozen embryo transfer cycles: a randomized controlled trial.
    Alsbjerg B; Kesmodel US; Elbaek HO; Laursen R; Laursen SB; Andreasen D; Povlsen BB; Humaidan P
    Reprod Biomed Online; 2022 Feb; 44(2):261-270. PubMed ID: 34924287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometriosis patients benefit from high serum progesterone in hormone replacement therapy-frozen embryo transfer cycles: a cohort study.
    Alsbjerg B; Kesmodel US; Humaidan P
    Reprod Biomed Online; 2023 Jan; 46(1):92-98. PubMed ID: 36216661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors associated with low serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cycles.
    Maignien C; Bourdon M; Marcellin L; Guibourdenche J; Chargui A; Patrat C; Plu-Bureau G; Chapron C; Santulli P
    Hum Reprod; 2022 Oct; 37(11):2570-2577. PubMed ID: 36125015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis.
    Cozzolino M; Pellicer N; Galliano D; Pellicer A
    Reprod Biomed Online; 2023 Jan; 46(1):150-155. PubMed ID: 36402667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study.
    Çakar E; Tasan HA; Kumru P; Cogendez E; Usal NT; Kutlu HT; Özkaya E; Eser SK
    J Obstet Gynaecol; 2020 Feb; 40(2):264-269. PubMed ID: 31455122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing.
    du Boulet B; Ranisavljevic N; Mollevi C; Bringer-Deutsch S; Brouillet S; Anahory T
    Front Endocrinol (Lausanne); 2022; 13():1051857. PubMed ID: 36531476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pregnancy bleeding after assisted reproductive technology: a systematic review and secondary data analysis from 320 patients undergoing hormone replacement therapy frozen embryo transfer.
    Nielsen JM; Humaidan P; Jensen MB; Alsbjerg B
    Hum Reprod; 2023 Dec; 38(12):2373-2381. PubMed ID: 37897214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.
    Pan D; Yang J; Zhang N; Wang L; Li N; Shi J; Zhou H
    Reprod Biol Endocrinol; 2022 Feb; 20(1):26. PubMed ID: 35115007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.